Biogen is a leading global biotechnology company that pioneers innovative science to deliver new medicines that transform patients’ lives and create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
In Canada, Biogen has been delivering life-changing medicines and services to Canadians affected by neurological conditions and rare disease for more than 25 years. Our team’s pioneering spirit and firm commitment to patients with complex diseases fuels our drive to innovate and help Canadians access ground-breaking treatments that can transform health, well-being and quality of life.
Making Breakthroughs Happen
Breakthroughs are more than milestones — they’re moments when hope turns into reality. For decades, Biogen has created medicines for hard-to-treat diseases. Scientific curiosity and aspirations to help people around the world are at the core of our legacy and our vision for the future.
